Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Wales
100%
Mycobacterium Tuberculosis (M. tb)
60%
United Kingdom
43%
Pre-exposure Prophylaxis (PrEP)
33%
95% Confidence Interval
26%
HIV Incidence
24%
HIV Testing
23%
Contact Tracing
23%
AIDS/HIV
23%
Genitourinary Medicine Clinic
23%
Prison
22%
Strain Typing
21%
Epidemiology
21%
Syphilis
20%
HIV Transmission
20%
Injecting Drug Users
19%
Phage Typing
19%
HIV Prevalence
19%
Antiretroviral Therapy
18%
HIV Infection
18%
Hepatitis C
18%
Unlinked
17%
Surveillance Data
17%
Hepatitis B
16%
Tuberculosis Epidemiology
16%
Risk Factors
15%
TB Incidence
14%
Hepatitis B Vaccine
14%
Hepatitis A
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Salmonella Enterica Serovar Typhimurium (S. Typhimurium)
12%
Health Protection Agency
12%
Salmonella
12%
Recent Transmission
11%
Public Health
11%
Tuberculosis Control
11%
Undiagnosed HIV
11%
HIV Pre-exposure Prophylaxis
11%
Northern Ireland
11%
Whole Genome Sequencing
11%
Thames
10%
Retrospective Cohort Study
10%
Molecular Epidemiology
10%
Salmonella Enteritidis (S. Enteritidis)
10%
Polonium-210
10%
Enhanced Surveillance
10%
Active Tuberculosis
10%
Cost-effectiveness
10%
Control Measures
10%
Undiagnosed Diseases
10%
Adjusted Odds Ratio
10%
HIV Epidemic
9%
Vaccination
9%
Epidemiological Study
9%
Sectional Analysis
9%
European Countries
9%
Social Risk
9%
Surveillance System
8%
General Practice
8%
Infection Rate
8%
HIV-positive
8%
Infection Detection
8%
Late HIV Diagnosis
8%
Tuberculosis Transmission
8%
Gastrointestinal Diseases
8%
Bayesian Evidence Synthesis
8%
Bovine Spongiform Encephalopathy
8%
Young Women
8%
Gonorrhea
8%
Food Poisoning
8%
Chlamydia
7%
Public Health Interventions
7%
Creutzfeldt-Jakob Disease
7%
Hepatitis C Virus Infection
7%
Active Transmission
7%
HIV Care
7%
Prevalence Rate
7%
Hepatitis B&C
7%
High Risk
7%
Human Immunodeficiency Virus Infection
7%
Israel
7%
Multivariable
7%
Recent Infection
7%
Vaccination Program
7%
Injector
7%
Rubella
7%
National Cohort Study
7%
Methicillin-resistant Staphylococcus Aureus
7%
Tuberculosis Contact Investigation
7%
Isoniazid-resistant Tuberculosis
7%
Perinatal Infection
7%
Non-disclosure
7%
Healthcare Workers
7%
Prevention Initiative
7%
Age Groups
7%
Internal Contamination
7%
Prospective Evaluation
7%
Ready-to-eat
7%
Salmonella Agona
7%
Epizootic
7%
Medicine and Dentistry
Human Immunodeficiency Virus
69%
Tuberculosis
65%
Men Who Have Sex with Men
43%
Pre-Exposure Prophylaxis
35%
Public Health
28%
Infection
26%
Sexually Transmitted Disease
19%
Diseases
18%
Cohort Effect
15%
Cross Sectional Study
15%
Contact Examination
15%
Syphilis
14%
Sexual Health Clinic
13%
Genitourinary Medicine
12%
Retrospective Cohort Study
10%
Molecular Epidemiology
10%
Health Care Cost
10%
Odds Ratio
10%
Antiretroviral Therapy
10%
Prophylaxis
9%
Index Case
9%
High Risk Population
9%
Human Immunodeficiency Virus Infection
9%
HIV Test
8%
Meningococcal Disease
8%
Prevalence
7%
Tandem Repeat
7%
Primary Health Care
7%
Pathogen
7%
Isoniazid
7%
Drug Resistant Tuberculosis
7%
Infection Prevention
7%
Polonium
7%
Whole Genome Sequencing
6%
Logistic Regression Analysis
6%
Epidemic
5%
Neisseria meningitidis
5%
Gastroenteritis
5%
Gastrointestinal Distress
5%
Reassurance
5%
Sexual Behavior
5%
Mycobacterium Tuberculosis
5%
Gonorrhea
5%